Microneedling Market Forecasts to 2030 – Global Analysis By Type (RF Microneedling and Laser Microneedling), Product (Dermapen, Dermaroller, Derma-Stamp and Other Products), Needle Material, Technique, Application, End User and By Geography
According to Stratistics MRC, the Global Microneedling Market is accounted for $601.31 million in 2023 and is expected to reach $1135.02 million by 2030 growing at a CAGR of 6.2% during the forecast period. Microneedling is a cosmetic procedure that uses small, sterilised needles to prick the skin. The importance of microneedling lies in its ability to stimulate collagen and elastin production, promote skin rejuvenation, and improve texture. It's used to address various skin concerns, including scars, wrinkles, fine lines, stretch marks, and hyperpigmentation. Microneedling can enhance the absorption of topical skincare products, making it an effective and versatile treatment for achieving smoother, firmer, and more youthful-looking skin.
According to the American Society for Dermatologic Surgery, sun damage is a top condition treated within the laser/light/energy-based devices, which increased by 14% year-over-year and up 22% from 2017 to 2020.
Market Dynamics:Driver:Rising beauty awareness
Aesthetics and personal appearance hold significant importance, and people are increasingly conscious of their skin's condition. Social media, beauty influencers, and the prevalence of image-driven platforms have fuelled a heightened awareness of skincare and appearance. This awareness has created a strong desire for solutions to address common skin issues such as fine lines, wrinkles, acne scars, and an uneven complexion. Moreover, microneedling offers a non-invasive and effective way to achieve these desired results, aligning with the growing preference for minimally disruptive cosmetic procedures. As a result, the demand for microneedling has surged, boosting the market.
Restraint:Risk of side effects
Infection, scarring, and hyperpigmentation are among the potential side effects, even though the surgery is usually seen as safe when carried out by qualified specialists. This risk increases if the patient neglects to follow post-treatment care recommendations or if the process is not conducted properly. Moreover, people with underlying medical issues or those taking medications that could influence the outcome may be reluctant due to fear of negative effects, which would further restrict the market's potential for expansion.
Opportunity:Technological advancements
Technological advancements have led to more precise and efficient microneedling procedures, enhancing the patient experience and treatment outcomes. Advanced microneedling devices now feature adjustable needle depths, improved safety mechanisms, and user-friendly interfaces, making treatments more customizable and comfortable. Integration with other technologies like radiofrequency (RF) or fractional lasers has optimised results by promoting collagen production and improving skin texture. In addition, specialty serums and skincare products designed to complement microneedling procedures further boost results and offer a holistic approach to skin rejuvenation. These technological advancements have expanded the range of applications, contributing to market growth.
Threat:Misuse and untrained practitioners
Microneedling requires a skilled and knowledgeable approach to ensure safety and optimal results. Possible side effects include insufficient results, infection, scarring, and hyperpigmentation if the operation is carried out by unskilled specialists. Those who experience these negative consequences can spread negative reviews, damaging the reputation of microneedling and deterring potential clients. The growing popularity of at-home microneedling technology raises this risk even more because individuals may use it without the required expertise. Thus, it is hampering market growth.
Covid-19 Impact
COVID-19 had a significant negative impact on the microneedling market since it restricted the use of elective cosmetic operations. During the lockdown, many clinics and spas temporarily closed, and consumers postponed non-essential treatments. The long-term impact may include an increased focus on safety and hygiene standards in the industry, as well as a continued shift towards home-based options. Regardless, the microneedling market is forming favourable opportunities post-pandemic owing to its high popularity and effectiveness. Similarly, the increasing adoption of drug-loaded microneedles to administer pharmaceutical formulations and the use of social media to spread knowledge about cosmetic procedures drive the increase in market revenue.
The Laser Microneedling segment is expected to be the largest during the forecast period
The Laser Microneedling segment is estimated to hold the largest share. Laser microneedling combines traditional microneedling with laser technology to treat skin concerns. It creates controlled injuries in the skin using fine needles, stimulating collagen production and improving skin texture. This minimally invasive procedure is important for precise and effective skin rejuvenation, scar treatment, and the overall enhancement of skin quality. Moreover, laser microneedling can address a wider range of skin issues, offering a more customised and effective approach to skin rejuvenation. This segment caters to individuals seeking advanced and targeted solutions for their skincare needs, contributing to the diversity and growth of the microneedling market.
The Dermaroller segment is expected to have the highest CAGR during the forecast period
The Dermaroller segment is anticipated to have lucrative growth during the forecast period. A dermaroller is a handheld cosmetic device equipped with a roller covered in tiny, medical-grade needles. It is used to create controlled micro-injuries in the skin, stimulating collagen production. This promotes skin rejuvenation, reduces the appearance of scars, wrinkles, and hyperpigmentation, and enhances product absorption. Moreover, dermatologists come in various needle lengths and are popular for at-home and professional use, offering a non-invasive and cost-effective solution for improving skin texture and appearance.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period due to the high investments in R&D activities in surgical procedures, along with awareness and acceptance of skin care procedures. Increasing use of radiofrequency microneedling for skin rejuvenation and partnerships between major companies in this region are driving revenue growth in the market. Furthermore, growing emphasis on personal grooming, more disposable income, and growing awareness of the benefits of microneedling procedures in nations like China, Japan, and India are the main factors driving the market's revenue growth.
Region with highest CAGR:
North America is expected to witness profitable growth over the projection period due to the rise in the popularity of skin rejuvenation and resurfacing treatments and the growing geriatric population. The rising incidence of alopecia and other dermatological conditions in this region are major factors driving the revenue growth of the microneedling market in North America. Moreover, major companies in the market are undergoing mergers and acquisitions and launching new products to expand their product portfolio while increasing their commercial footprint on a global scale.
Key players in the marketSome of the key players in the Microneedling Market include Lumenis, Cynosure, Cutera, EndyMed Medical Ltd, Environ Skin Care, Candela Medical, Eclipse Med Global, Lutronic, Derma Quip, Dermaroller GmbH, Shenb Co. Ltd., Crown Aesthetics, Veroderm Medical Technologies, Timpac Healthcare, Nubway Co. Ltd., Sincoheren Ltd. and Beijing Sanhe Beauty S & T Co., Ltd.
Key Developments:In March 2022, Cynosure announced a distribution partnership with a subsidiary of Jeisys Medical Inc., which is headquartered in Japan. This partnership will enable the latter company to have exclusive distribution rights in Japan for products of energy-based laser portfolio of Cynosure.
In 24 May 2022, Crown Laboratories announced to acquire aesthetic-focused assets of Eclipse Medcorp, LLC. Product portfolio of the former company will expand to offer dermatological and aesthetic medicinal services and products to customers and will consequently increase customer base..
Types Covered:
• RF Microneedling
• Laser Microneedling
Products Covered:
• Dermapen
• Dermaroller
• Derma-Stamp
• Other Products
Needle Materials Covered:
• Silicon Microneedle
• Glass Hollow Microneedle
• Metal Microneedle
Techniques Covered:
• Automated
• Manual
Applications Covered:
• Skin Rejuvenation
• Acne
• Wrinkles
• Alopecia
• Traumatic & Surgical Scars
• Other Applications
End Users Covered:
• Hospitals
• Homecare Settings
• Dermatology Clinics
• Ambulatory Surgical Centers
• Other End Users
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements